The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
The burden of illness in Lennox–Gastaut syndrome: a systematic literature review
Open accessAbstract
Background: Lennox–Gastaut syndrome (LGS) is a severe developmental and epileptic encephalopathy characterized by drug-resistant epilepsy with multiple seizure types starting in childhood, a typical slow spike-wave pattern on electroencephalogram, and cognitive dysfunction. Methods: We performed a systematic literature review according to the PRISMA guidelines to identify, synthesize and appraise the burden of illness in LGS (including “probable” LGS). Studies were identified by searching MEDLINE, Embase and APA PsychInfo, Cochrane’s database of systematic reviews, and Epistemonikos. The outcomes were epidemiology (incidence, prevalence or mortality), direct and indirect costs, healthcare resource utilization, and patient and caregiver health-related quality of life (HRQoL). Results: The search identified 22 publications evaluating the epidemiology (n = 10), direct costs and resource (n = 10) and/or HRQoL (n = 5). No studies reporting on indirect costs were identified. With no specific ICD code for LGS in many regions, several studies had to rely upon indirect methods to identify their patient populations (e.g., algorithms to search insurance claims databases to identify “probable” LGS). There was heterogeneity between studies in how LGS was defined, the size of the populations, ages of the patients and length of the follow-up period. The prevalence varied from 4.2 to 60.8 per 100,000 people across studies for probable LGS and 2.9–28 per 100,000 for a confirmed/narrow definition of LGS. LGS was associated with high mortality rates compared to the general population and epilepsy population. Healthcare resource utilization and direct costs were substantial across all studies. Mean annual direct costs per person varied from $24,048 to $80,545 across studies, and home-based care and inpatient care were significant cost drivers. Studies showed that the HRQoL of patients and caregivers was adversely affected, although only a few studies were identified. In addition, studies suggested that seizure events were associated with higher costs and worse HRQoL. The risk of bias was low or moderate in most studies. Conclusions: LGS is associated with a significant burden of illness featuring resistant seizures associated with higher costs and worse HRQoL. More research is needed, especially in evaluating indirect costs and caregiver burden, where there is a notable lack of studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig 1 Timeline to show A the history of the characterization and treatment of LGS B the triad of symptoms characteristic of LGS and the clinical implications of the characterization of the syndrome. From: Lennox et al (1950) [1], Gastraut et al (1966) [2], Niedermeyer (1969) [90], Beaumanoir (1985) [91], ILAE 1989 [92], Engel (2001) [93], Arzimanoglou et al (2009) [3], Scheffer (2017) [94], World Health Organization (ICD-11) (2022) [64]. CLB, clobazam; CBD, cannabidiol; EEG, electroencephalogram; FFA, fenfluramine; FLB, felbamate; ILAE, International League Against Epilepsy; LGS, Lennox–Gastaut syndrome; LTG, lamotrigine; RUF, rufinamide; TPM, topiramate](https://figures.cochat.ai/paper-figures/a20bdf042bff42698a482fd9b6342aee/the-burden-of-illness-in-lennoxgastaut-syndrome-a-systematic-literature-review-figure-1.jpg)
![Fig 2 PRISMA flow diagram. Adapted from Page et al (2021) [95]](https://figures.cochat.ai/paper-figures/77899e080a3b4c369d4d0b81bf13fa0f/the-burden-of-illness-in-lennoxgastaut-syndrome-a-systematic-literature-review-figure-2.jpg)
![Fig 3 A Total direct costs in LGS patients (blue) versus control patients (grey), patients with other epilepsies (lilac), and in LGS patients with seizure events vs without seizure events and LGS patients in years where patients were prescribed with rescue medication vs years where patients were not prescribed rescue medication (blue) B resource utilization and costs in LGS patients vs controls; C resource utilization and costs in LGS patients with seizure events vs without seizure events. Adapted from: Reaven et al (2018) [54], Piña-Garza et al (2017) [46], Stockl et al (2019) [55], Hollenack et al (2019) [52], Reaven et al (2019) [53] and Strzelczyk et al (2021) [47] .* Costs were converted from Euros to US dollars on 21st June 2022 (exchange rate 1.00 Euro =1.06 US Dollars [xe.com]). ASM, anti-seizure medication; DS, Dravet syndrome; ED, emergency department; LGS, Lennox–Gastaut syndrome; PPPY, per person per year; OP, outpatient; TSC, tuberous sclerosis complex](https://figures.cochat.ai/paper-figures/74dcb6fa634145bebe818f8645621dc4/the-burden-of-illness-in-lennoxgastaut-syndrome-a-systematic-literature-review-figure-3.jpg)
![Fig 4 A Cost drivers according to inpatient and emergency department admissions (red), outpatient visits (orange), home health (home nursing and physiotherapy; blue), equipment (yellow) and medication (green) costs (where reported) B Patient and caregiver HRQoL according to number of drop seizures per month and number of seizure-free days in the UK and France. Mean health state utility scores for a hypothetical patient with LGS and a hypothetical caregiver of a patient with LGS. A Adapted from: Strzelczyk et al (2021) [47] and Reaven et al (2018) [54]. Home health= home-based nursing, personal care, and residential habilitation services. B Adapted from Auvin et al (2021) [61]. ASM, anti-seizure medication; ED, emergency department; HRQoL, health-related quality of life; OP, outpatient](https://figures.cochat.ai/paper-figures/3ccc11852d9049b9b4913761a3257f4a/the-burden-of-illness-in-lennoxgastaut-syndrome-a-systematic-literature-review-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Parents of children with LGS, the vast majority mothers, reported constant anxiety, difficulties in accessing childcare, restriction of social life and poor mental health 229,230 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [230]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054 · cited 1×
“From: Lennox et al (1950) [1], Gastraut et al (1966) [2], Niedermeyer (1969) [90], Beaumanoir (1985) [91], ILAE 1989 [92], Engel (2001) [93], Arzimanoglou et al (2009) [3], Scheffer (2017) [94], World Health Organization (ICD‐11) (2022) [64].”
BackgroundSelf-citationMethods for the economic evaluation of health care programmes
Wilson, S. H. (1987) · Journal of Epidemiology and Community Health · doi:10.1136/jech.41.4.355-a · Cited by 4,275 · cited 1×
“The quality of the cost of illness studies was assessed using a tool from the British Medical Journal Checklist for economic submissions [36] that was adapted by Molinier et al.”
MethodHoy, D., Brooks, P., Woolf, A., Blyth, F., March, L., Bain, C., Baker, P., Smith, E., & Buchbinder, R. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.11.014 · Cited by 2,555
Engel, J. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.10401.x · Cited by 2,251 · cited 1×
“From: Lennox et al (1950) [1], Gastraut et al (1966) [2], Niedermeyer (1969) [90], Beaumanoir (1985) [91], ILAE 1989 [92], Engel (2001) [93], Arzimanoglou et al (2009) [3], Scheffer (2017) [94], World Health Organization (ICD‐11) (2022) [64].”
Background
Research works printed but not linked: 4
- Covidence. Systematic review management platform [Available from: https://www.covidence.org/]
- Hollenack K, Story T, Acs A, et al. Prevalence of probable dravet syndrome, Lennox–Gastaut syndrome, and other refractory epilepsies in commercial and medicaid populations in the United States. J Manag Care Spec Pharm. 2019;25(3-A SUPPL):S58.
- Stockl K, Funk S, Reaven N, et al. Inpatient hospitalizations and readmissions among patients with probable Lennox–Gastaut syndrome, dravet syndrome, tuberous sclerosis complex, and other refractory epilepsies. J Manag Care Spec Pharm. 2019;25(10-A SUPPL):S57–8.
- Umeno J. A survey on the utilization status of social welfare services for pediatric patients with epilepsy. [Japanese]. No To Hattatsu. 2019;51(4):23–49.
Cited by
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
“Parents of children with LGS, the vast majority mothers, reported constant anxiety, difficulties in accessing child care, restriction of social life and poor mental health 229,230 .”
Self-citationSullivan, J. E., Benitez, A., Roth, J., Andrews, J. S., Shah, D., Butcher, E., Jones, A., & Cross, J. H. (2024) · Epilepsia · doi:10.1111/epi.17866 · Cited by 86
“A paucity of studies focusing on LGS was observed despite this condition having been recognized for longer than DS. 110,111 These issues, identified in the present analysis, make it difficult to draw reliable conclusions about the epidemiology of DS and LGS. Strzelczyk et al. 112 recently conducted a systematic litera…”
Dravet syndrome: A systematic literature review of the illness burden
Strzelczyk, A., Lagae, L. G., Wilmshurst, J. M., Brunklaus, A., Striano, P., Rosenow, F., & Schubert‐Bast, S. (2023) · Epilepsia Open · doi:10.1002/epi4.12832 · Cited by 78
“12,77,78 Further differences in costs and resource use between the different studies may be due to differences in study design (e.g., data sources, included cost components, cost-year, and different costs in different countries), as well as differences in access to different treatments and…”
BackgroundSelf-citationAuvin, S., Arzimanoglou, A. A., Falip, M., Striano, P., & Cross, J. H. (2024) · Epilepsia Open · doi:10.1002/epi4.13075 · Cited by 55
“115 LGS adversely affects the QoL of both patients and caregivers 20,116–118 ; seizure control (particularly drop seizure control) and days without seizures being the main determinants of QoL in LGS. 119,120 From childhood to adulthood, management of LGS must carefully balance the burden of…”
Self-citationCross, J. H., Benitez, A., Roth, J., Andrews, J. S., Shah, D., Butcher, E., Jones, A., & Sullivan, J. E. (2024) · Epilepsia · doi:10.1111/epi.17932 · Cited by 48
“Additionally, multiple types of motor deficits with varying prevalence were reported, reflecting the complex presentation of LGS.”
BackgroundInfluential
Metadata
- Authors
- Strzelczyk, A., Zuberi, S. M., Striano, P., Rosenow, F., & Schubert-Bast, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Royal Hospital for Children (GB)
- Istituto Giannina Gaslini (IT)
- Corresponding author
- Strzelczyk, Adam
- Venue
- Orphanet Journal of Rare Diseases
- Published
- 2023-03-01
- Volume
- 18
- Issue
- 1
- Pages
- 42-42
- ISSN
- 1750-1172 (ISSN-L)
- PMC
- PMC9979426
- OpenAlex
- W4322733387
- Cited by
- 68
- References
- 87
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 20 · 2023: 4
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Orphanet Journal of Rare Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by)
- Funders
- Johann Wolfgang Goethe-Universität, Frankfurt am Main
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- Lennox-Gastaut syndrome, disease burden, drug-resistant epilepsy, developmental and epileptic encephalopathy, prevalence, incidence, mortality, health care costs, healthcare resource utilization, health-related quality of life, caregiver burden, indirect costs
- MeSH terms
- Algorithms, Humans, Quality of Life, Seizures, Cost of Illness, Lennox Gastaut Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The burden of illness in Lennox–Gastaut syndrome: a systematic literature review. https://app.cochat.ai/papers/10.1186/s13023-023-02626-4
- The paper
- Strzelczyk, A., Zuberi, S. M., Striano, P., Rosenow, F., & Schubert-Bast, S. (2023). The burden of illness in Lennox–Gastaut syndrome: a systematic literature review. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-023-02626-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.